Skip to collection list Skip to video grid

All Video Abstracts

Utility of DAT in Low-Risk Neonates with ABO or RhD Incompatibility

Routine direct antiglobulin testing adds no predictive value beyond transcutaneous bilirubin monitoring for ABO or RhD incompatible neonates, supporting the discontinuation of universal screening.

Read More
Read Less

categories